JMP Securities maintains $220 target on Digital Realty stock
JMP Securities reiterated its Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of ...
CyberArk stock target lifted to $480 by JMP Securities
JMP Securities enhanced its outlook on CyberArk Software (NASDAQ:CYBR) shares, raising the price target to $480 from the previous $390. This adjustment comes in the wake of CyberArk's impressive ...
JMP Securities Raises Axon Enterprise, Inc. (AXON) Price Target to $725 on AI & Defense Demand
We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...
Enova International (NYSE:ENVA) Given New $135.00 Price Target at JMP Securities
Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...
Investing10d
Alphabet shares drop following JMP Securities rating
The decline comes as the stock trades near its 52-week high of $207.05, with InvestingPro data showing a robust 44% return over the past year. JMP Securities highlighted Alphabet's current trading ...
Investing15d
JMP Securities reiterates Uber stock Market Perform rating
The analysis by JMP Securities indicates that the risk/reward ... of $140.22 billion and a P/E ratio of 31.59, InvestingPro data shows Uber trading near its Fair Value. The commentary from JMP ...
Yahoo Finance18d
Reddit Inc. (RDDT): JMP Securities Raises Target to $190 on AI Innovations, Data Licensing Deals, and Q4 Advertising Momentum
We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database ...
Rezolute price target raised to $9 from $8 at JMP Securities
JMP Securities analyst Jason Butler raised the firm’s price target on Rezolute (RZLT) to $9 from $8 and keeps an Outperform rating on the ...
Enanta Pharmaceuticals’ (ENTA) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...